Roles of registered nurses in antimicrobial stewardship Junel - - PowerPoint PPT Presentation

roles of
SMART_READER_LITE
LIVE PREVIEW

Roles of registered nurses in antimicrobial stewardship Junel - - PowerPoint PPT Presentation

Roles of registered nurses in antimicrobial stewardship Junel Padigos BScN, RN, PGDipHSc Registered Nurse Department of Critical Care Medicine Auckland City Hospital Stephen Ritchie MBChB, PhD Consultant, Infectious Diseases Auckland


slide-1
SLIDE 1

Junel Padigos BScN, RN, PGDipHSc Registered Nurse Department of Critical Care Medicine Auckland City Hospital Stephen Ritchie MBChB, PhD Consultant, Infectious Diseases Auckland District Health Board Anecita Gigi Lim RN, PhD Senior Lecturer, School of Nursing The University of Auckland

Roles of registered nurses in antimicrobial stewardship

slide-2
SLIDE 2

“ In such cases , the thoughtless person playing with penicillin is morally res pons ible for the death of the man who finally succumbs to infection with the penicillin- resistant organism.”

S ir Alexander Fleming (26 June 1945)

slide-3
SLIDE 3

Acknowledgment

Dr Stephen Ritchie (Consultant, ADHB Infectious Diseases) Dr Anecita Gigi Lim (Senior Nursing Lecturer, The University of Auckland) Margaret Dotchin (Chief Nursing Officer, ADHB) Denise Kivell (Chief Nurse, CMH) Karyn Sangster (Chief Nurse Adviser, CMH Primary Care) Anne Goddard (Nurse Specialist, CMH Medication Safety) Heather Howard (Nurse Manager, DCCM ADHB) ADHB and CMDHB Research Offices and Communications Team New Zealand Nurses Organisation All participants (Registered nurses in the greater Auckland region)

slide-4
SLIDE 4

What is antimicrobial stewardship?

Antimicrobial s tewardship is a coordinated program that promotes

  • 1. appropriate us

e of antimicrobials (including antibiotics),

  • 2. improves

patient outcomes ,

  • 3. reduces

microbial res is tance, and

  • 4. decreas

es the s pread of infections caus ed by multidrug- resistant organisms .

Association for Professionals in Infection Control and Epidemiology, 2016

slide-5
SLIDE 5

World Health Organization recommendation

  • a. WHO global AMR surveillance report (2014)

highlighted that AMR is a serious global threat to public health.

  • b. WHO calls for a multidisciplinary approach
  • f AMS programme in all health care

institutions across the globe to facilitate appropriate antibiotic use (WHO, 2015).

slide-6
SLIDE 6

Rationale of antibiotic use

  • Treating infections

Centres for Dis eas e Control and P revention (2011) s tated that “ Half of US hos pital patients were taking antibiotics ; 25 percent on two or more” .

  • In the agriculture, antibiotics

are us ed to promote growth of lives tock.

slide-7
SLIDE 7

What has gone wrong?

In New Zealand, evidence suggested irrational antibiotic use nationally and a rising rate of AMR particularly in Auckland. NZ has smaller incidence rates of AMR compared to other countries; however, there is a rising rate (Thompson, 2013; Thomas et al., 2014; MOH, 2016). P harmacy sales in 71 countries revealed very high antibiotic use in New Zealand, as evidenced by an increase in use per person from 26 units in 2000 to 70 units in 2010 (Van Boeckel et al., 2014).

slide-8
SLIDE 8

What has gone wrong?

Rural Context In Tairāwhiti, 51% of the population were prescribed one or more antibiotics in the year during which the study was undertaken, suggesting high antibiotic use (Norris et al., 2011). As implied by Norris et al. (2011), underpres cription of antibiotics in high-risk Māori and P acific Island populations and overpres cription of antibiotics in the general population highlights a dis parity in pres cribing whereby antibiotics are being injudiciously prescribed for a low-risk population.

slide-9
SLIDE 9

Mechanisms of antimicrobial resistance

1.Active efflux 2.Target replication 3.Drug target modification 4.Decreased cell wall permeability 5.Enzyme acquisition and production

slide-10
SLIDE 10

Risks with antibiotic use

  • a. Antibiotic res

is tance

  • b. Advers

e drug events and allergies

  • c. Drug s

ide effects

  • d. Clos

tridium difficile infection

  • e. Antibiotic as

s

  • ciated diarrhoea/ colitis

f.

Increas ed morbidity and mortality

  • g. Increas

ed health-care expenditure

  • h. Alteration of the human microbiota
slide-11
SLIDE 11

The human microbiota

a. The human microbiota refers to the vast collection of microorganisms that naturally colonise the human body, including the skin, nose, and gastrointestinal and genitourinary tracts (Madigan et al., 2015). b. There are an estimated 1014 (100 trillion) microorganisms in the human microbiome, which is approximately 10 times more than the total number of cells in the human body (Madigan et al., 2015).

slide-12
SLIDE 12

What registered nurses can do?

  • 1. Ris

k reduction e.g., by checking allergy status and reducing IV line days (Gillespie et al., 2013; Fehily et al., 2015)

slide-13
SLIDE 13

What registered nurses can do?

  • 2. Initiation or escalating a convers

ation about the need for early and appropriate blood cultures for patients suspected to have seps is .

slide-14
SLIDE 14

What registered nurses can do?

  • 3. Ensuring that antimicrobial treatment

is in line with microbiology results and reviewing the need for antibiotics (Edwards et al., 2011)

slide-15
SLIDE 15

What registered nurses can do?

  • 4. Checking that an antibiotic

pres cription is in agreement with antibiotic guidelines or protocols (Edwards et al., 2011)

slide-16
SLIDE 16

What registered nurses can do?

  • 5. Monitoring ADRs to antibiotics
  • r

development of antibiotic resistance (Olans et al., 2016)

slide-17
SLIDE 17

What registered nurses can do?

  • 6. Checking that antimicrobial therapy is

pres cribed and in line with its standard recommended duration.

slide-18
SLIDE 18

What registered nurses can do?

  • 7. Initiating dis

cus s ion of s witching IV to oral antimicrobial therapy (Edwards et al., 2011)

slide-19
SLIDE 19

What registered nurses can do?

  • 8. Checking that s

urgical antibiotic prophylaxis is pres cribed for the appropriate duration as recommended (Edwards et al., 2011)

slide-20
SLIDE 20

What registered nurses can do?

  • 9. Ens

uring that antibiotics are initiated and adminis tered at the correct time as pres cribed and recommended

slide-21
SLIDE 21

What registered nurses can do?

  • 10. Decis

ion-making on patient s uitability for outpatient IV antibiotic s ervices (Edwards et al., 2011)

slide-22
SLIDE 22

What registered nurses can do?

  • 11. Education and advocacy

for implementation of antimicrobial s tewards hip practices in the workplace

slide-23
SLIDE 23

What registered nurses can do?

  • 12. P

atient and family education, e.g., s afe antibiotic us e and immunis ation agains t avoidable infectious illnes s es

slide-24
SLIDE 24

Where is the gap?

A multidis ciplinary approach, involving all HCPs is needed to combat AMR (Charani et al., 2014). The roles

  • f doctors

and pharmacis ts are very well contextualis ed in AMS .

  • a. The role of regis

tered nurs es (RNs ) in this regard,

  • ther than as

infection control practitioners is not well-unders tood.

  • b. Little is

known about the knowledge of practis ing RNs concerning us e of antibiotics , AMR and es pecially in the New Zealand context.

slide-25
SLIDE 25

RESEARCH FINDINGS

slide-26
SLIDE 26

Aim

This s tudy as s es s ed knowledge of nurs es concerning antibiotics , AMR and AMS; and to as s es s their perceptions

  • n the

potential roles as antimicrobial s tewards .

slide-27
SLIDE 27

Methods

An online survey was used (Qualtrics survey software) (purely quantitative). Ethical approval procured from The University of Auckland, ADHB and CMH Research Offices . 369 attempts; (N= 298) participants completed the survey. Descriptive and inferential statistics were used.

slide-28
SLIDE 28

Knowledge on antibiotics, AMR and AMS

55 8 3 91 40 19 112 164 165 34 75 101 6 11 10 20 40 60 80 100 120 140 160 180 Antimicrobial Stewardship (Median=3; IQR=1) Antimicrobial Resistance (Median=3; IQR=1) Antibiotics (Median=3; IQR=1)

Total Number of Participants = 298

Excellent Above Average Average Below Average Very Poor

slide-29
SLIDE 29

251 47 84 16 50 100 150 200 250 300 No Yes

Total Number of Participants = 298

Percentage Responses

Have you heard of AMS being implemented in your place of work?

slide-30
SLIDE 30

4 2 6 15 7 8 2 2 4 6 22 37 23 12 11 5 37 41 58 74 79 91 24 17 100 120 105 95 106 92 124 109 153 129 107 77 83 95 137 165 20 40 60 80 100 120 140 160 180 Failure to complete course of treatment of prescribed antibiotics (Median=5; IQR=1) Poor patient adherence to treatment regimen (Median=4; IQR=1) Poor infection control practices e.g. hand hygiene (Median=4; IQR=2) Excessive use of antibiotics in livestock industry (Median=4; IQR=2) Prolonged/frequent hospital care (Median=4; IQR=2) Prescription of the wrong doses of antibiotics (Median=4; IQR=2) Prescription of unnecessary broad-spectrum antibiotics (Median=4; IQR=2) Unnecessary use of antibiotics (Median=5; IQR=1)

Total Number of Participants = 298

Extremely Significant Very Significant Moderately Significant Slightly Significant Not Significant

Causes of AMR

slide-31
SLIDE 31

92 64 101 211 164 187 92 155 201 175 31 21 34 71 55 63 31 52 67 59 50 100 150 200 250 Leadership in the workplace Limited computers to access guidelines Support from nursing colleagues Background knowledge Facilitating staff education Support from physicians Managerial support Workplace culture Time constraints Patient load

Total Number of Participants = 298

Percentage Response

Challenges in integrating AMR in clinical practice

slide-32
SLIDE 32

298 286 277 12 21 50 100 150 200 250 300 350 Antimicrobial Stewardship Antimicrobial Resistance Antibiotics

Total Number of Respondents = 298

No Yes

Do you want further training and education on the following?

slide-33
SLIDE 33

3 5 5 1 6 6 34 25 85 139 130 209 114 132

  • 30

20 70 120 170 220 Workplace (Median=4; IQR=1) Postgraduate Nursing School (Median=4; IQR=1) Undergraduate Nursing School (Median=4; IQR=1)

Total Number of Participants = 298

Strongly Agree Agree Undecided Disagree Strongly Disagree

Where should further training and education on AMS be facilitated?

slide-34
SLIDE 34

Conclusion

Nurs es play vital roles , in addres s ing AMR and in contributing to AMS efforts . Therefore, further training and education to addres s health literacy needs

  • f RNs

and their roles in AMS is paramount.

slide-35
SLIDE 35

The WHO recommended a multidisciplinary approach to proper use of antibiotics. Not including nurses and not responding to the learning needs of nurses for further training and education on Antimicrobial Stewardship

DOE OES S NOT OT SE SERV RVE A TRU RUE MU MULTIDISC IDISCIPLIN IPLINAR ARY Y APP PPRO ROACH. H.

slide-36
SLIDE 36

Where do we go from here?

  • 1. Collaborate with AMS

committee, nursing and medical leaders in health care institutions .

  • 2. Invite the Nursing Council of New Zealand, NZNO,

College of Nurses Aotearoa to issue a position statement in line with that of the Ministry of Health.

  • 3. Education in all levels: undergraduate, postgraduate

and in the workplace.

  • 4. Widespread campaign on safe antibiotic use.
  • 5. Further research on nursing involvement in

antimicrobial stewardship programme.

slide-37
SLIDE 37

BATTLING ANTIMICROBIAL RESISTANCE IS A

HER HERCULEAN CULEAN TAS ASK. K.

slide-38
SLIDE 38

Association of Professionals for Infection Control and Epidemiology (2016). Antimicrobial stewardship. Accessed from http://www.apic.org/Professional-Practice/Practice-Resources/Antimicrobial-Stewardship Centers for Disease Prevention and Control (2011). Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. Accessed from http://jama.jamanetwork.com/article.aspx?articleid=1911328 Charani, E., Castro-Sanchez, E., Holmes, A. (2014). The role of behavior change in antimicrobial stewardship. Infectious Disease Clinics of North America, 28(2), 169-175. doi: 10.1016/j.idc.2014.01.004 Edwards, R., Drumright, L., Kiernan, M., Holmes, A. (2011). Covering more territory to fight resistance: considering nurses’ role in antimicrobial stewardship. Journal of Infection Prevention, 12(1), 6–10. doi: 10.1177/1757177410389627 Fehily, S., Stuart, R., Horne, K., Korman, T ., Dendle, C. (2015). Who really knows their patients' penicillin adverse drug reaction status? A cross‐sectional survey. Internal Medicine Journal, 45(1), 113-115. Fleming, A. (1945, June 26). Penicillin's finder assays its future. New York Times, p. 21. Gillespie, E., Rodrigues, A., Wright, L., Williams, N., Stuart, R. (2013). Improving antibiotic stewardship by involving nurses. American Journal of Infection Control, 41(4), 365-367.

References

slide-39
SLIDE 39

Madigan M., Martinko, J., Bender, K., Buckley, D., Stahl, D. (2015). Brock biology of microorganisms (14th ed.). Harlow, England: Pearson Education Limited. Ministry of Health (MOH) (2016)1. Antimicrobial Resistance. Accessed from http://www.health.govt.nz/our- work/diseases-and-conditions/antimicrobial-resistance Olans, R., Nicholas, P ., Hanley, D., DeMaria, A. (2015). Defining a role for nursing education in staff nurse participation in antimicrobial stewardship. Journal of Continuing Education in Nursing, 46(7), 318-321. Thomas, M., Smith, A., Tilyard, M. (2014). Rising antimicrobial resistance: a strong reason to reduce excessive antimicrobial consumption in New Zealand. New Zealand Medical Journal, 127(1394), 72-84. Thompson, I. (2013). Antimicrobial Stewardship in New Zealand. Accessed from http://www.hqsc.govt.nz/assets/Infection-Prevention/PR/Antimicrobial-stewardship-report.pdf Van Boeckel, T ., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B., Levin, S. …Laxminarayan, R. (2014). Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infectious Diseases, 14(8), 742-750. World Health Organization (WHO) (2014). Global report on surveillance on antimicrobial resistance. Accessed from http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1 World Health Organization (WHO) (2015). Global Action Plan on Antimicrobial Resistance. Accessed from http://apps.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1

slide-40
SLIDE 40

Images in the slides were taken via www.google.com and can be accessed using the following links: Construction Specialties (accessed September 2016). Accessed from http://www.cs- group.co.nz/projects/nz/aucklandhos/ PortalEnf Comunidade de Saúde (accessed September 2016). Accessed from https://www.portalenf.com/etiqueta/antibioticos/ Sri Lankan National Surveillance on Antimicrobial Resistance (accessed September 2016). Accessed from http://slmicrobiology.net/national-surveillance-of-antimicrobial-resistance/ Alexander Fleming (accessed September 2016) Accessed from http://college.lutterbach.free.fr/EISE/exposes2013/Fleming/fleming.html What’s in the Human Microbiome? (accessed September 2016). Accessed from http://allergiesandyourgut.com/tag/microbiome-brain-interact/ Human Longevity, Inc (accessed September 2016). Accessed from http://www.humanlongevity.com/science-technology/science/microbiome-metabolome/ Insurance Age (accessed September 2016). Accessed from http://www.insuranceage.co.uk/insurance- age/news-analysis/2343044/gallagher-faces-herculean-integration-task